In addition, CCL2, CCL11, CCL14, CCL18, CCL19, CCL21, CCL23, CCL24, CCL26 were markedly related with clinical stage in BC patients and CC chemokines were related to cytokine activity, chemokines receptor binding, chemotaxis immune cell migration. This evidence concerns the gene CCL19 and breast cancer.